Cargando…

Successful Treatment of Persistent Coronavirus Disease 2019 Infection in a Patient With Hypogammaglobulinemia With REGN-COV2: A Case Report

A 55-year-old man with hypogammaglobulinemia due to previous rituximab treatment developed persistent coronavirus disease 2019 pneumonia. Treatment with REGN-COV2 (casirivimab and imdevimab) resulted in the clearance of the infection. Targeted antiviral antibodies may be an important weapon in the m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luitel, Pankaj, Vais, Dana, Gidron, Adi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344477/ https://www.ncbi.nlm.nih.gov/pubmed/34405092 http://dx.doi.org/10.1093/ofid/ofab335

Ejemplares similares

Extended Remdesivir Infusion for Persistent Coronavirus Disease 2019 Infection
por: Martinez, Mario A, et al.
Publicado: (2022)

Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy
por: Taha, Yusri, et al.
Publicado: (2021)

High titer of antibody against the SARS-CoV-2 spike protein among patients receiving neutralizing antibody cocktail therapy with REGN-COV
por: Sasaki, Hiroaki, et al.
Publicado: (2022)

Persistent and fatal severe acute respiratory syndrome coronavirus 2 infection in a patient with severe hypogammaglobulinemia: a case report
por: Bedoya-Joaqui, Vanessa, et al.
Publicado: (2023)

Recurrent and persistent respiratory tract viral infections in patients with primary hypogammaglobulinemia
por: Kainulainen, Leena, et al.
Publicado: (2010)

A COVID-19 family cluster with retinitis pigmentosa and hypogammaglobulinemia
por: Alshukairi, Abeer N., et al.
Publicado: (2022)

REGN-EB3: First Approval
por: Markham, Anthony
Publicado: (2021)

Endogenous antibody responses in REGN-COV2-treated SARS-CoV-2-infected individuals
por: Kurshan, Ashwini, et al.
Publicado: (2023)

REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters
por: Baum, Alina, et al.
Publicado: (2020)

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
por: Weinreich, David M., et al.
Publicado: (2020)

Le régne de l'esprit malin
por: Ramuz, C. F. (Charles Ferdinand), 1878-1947
Publicado: (1946)

Casirivimab-Imdevimab (REGN-COV2) for Mild to Moderate SARS-CoV-2 Infection in Kidney Transplant Recipients
por: Liu, Esther C., et al.
Publicado: (2021)

Case report: Clinical course and treatment of SARS-CoV-2 in a pediatric CAR-T cell recipient with persistent hypogammaglobulinemia
por: Sanders, Howard, et al.
Publicado: (2023)

Hypogammaglobulinemia with Facial Edema
por: Knight, Adina Kay, et al.
Publicado: (2006)

Rituximab Use and Hypogammaglobulinemia
por: Alhassan, Eaman, et al.
Publicado: (2020)

Case report: Persistent hypogammaglobulinemia in thymoma-associated myasthenia gravis: the impact of rituximab or Good's syndrome?
por: Ren, Jingru, et al.
Publicado: (2023)

606 Case Report: Hypogammaglobulinemia Induced by Oxcarbazepine
por: Marinovic, Maria Angelica, et al.
Publicado: (2012)

PD42 - Is rituximab a trigger for persistent hypogammaglobulinemia in idiopathic nephrotic syndrome?
por: Trujillo, Juan Enrique, et al.
Publicado: (2014)

Case Report: Persistent Hypogammaglobulinemia More Than 10 Years After Rituximab Given Post-HSCT
por: Luterbacher, Fanny, et al.
Publicado: (2021)

Tonsillar granuloma associated with hypogammaglobulinemia
por: Laajala, Aleksi, et al.
Publicado: (2020)

Lymphocytosis, Lymphocytopenia, Hypergammaglobulinemia, and Hypogammaglobulinemia
por: Mims, Martha P.
Publicado: (2018)

COVID-19, plasma, and hypogammaglobulinemia
por: Murphy, Michael F., et al.
Publicado: (2020)

Therapy With Allogeneic Severe Acute Respiratory Syndrome Coronavirus-2–Specific T Cells for Persistent Coronavirus Disease 2019 in Immunocompromised Patients
por: Haidar, Ghady, et al.
Publicado: (2023)

Characterization of infections and hypogammaglobulinemia treated with the combination of pertuzumab and trastuzumab
por: Mortimer, Joanne E., et al.
Publicado: (2019)

Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab
por: Perriguey, Marine, et al.
Publicado: (2021)

COVID-19 Virus Infection in Three Patients With Hypogammaglobulinemia
por: Gesiotto, Quinto, et al.
Publicado: (2021)

Successful Treatment of Persistent Symptomatic Coronavirus Disease 19 Infection With Extended-Duration Nirmatrelvir-Ritonavir Among Outpatients With Hematologic Cancer
por: Liu, Catherine, et al.
Publicado: (2023)

Compassionate use of REGN-COV2 in the treatment of COVID-19 in a patient with impaired humoral immunity
por: Nguyen, Hanna, et al.
Publicado: (2021)

Melatonin and REGN-CoV2 combination as a vaccine adjuvant for Omicron variant of SARS-CoV-2
por: Haskologlu, Ismail Celil, et al.
Publicado: (2022)

Un « @-CPLF » sous le règne de la COVID-19
por: Schlemmer, F.
Publicado: (2021)

Familial occurrence of warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome
por: Siedlar, Maciej, et al.
Publicado: (2008)

Role of Hypogammaglobulinemia in Invasive Fungal Infections in Children May Be Overlooked
por: Zhu, Jingnan, et al.
Publicado: (2022)

Persistent Hypogammaglobulinemia after Receiving Rituximab Post-HSCT Is Not Caused by an Intrinsic B Cell Defect
por: Ott de Bruin, Lisa M., et al.
Publicado: (2023)

Immunoglobulin Replacement Therapy in Secondary Hypogammaglobulinemia
por: Compagno, Nicolò, et al.
Publicado: (2014)

Hypogammaglobulinemia due to CAR T-cell therapy
por: Doan, Andrew, et al.
Publicado: (2017)

Hypogammaglobulinemia: a diagnosis that must not be overlooked
por: Pimenta, F.M.C.A., et al.
Publicado: (2019)

Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease
por: Tieu, Joanna, et al.
Publicado: (2021)

Hypogammaglobulinemia in pediatric kidney transplant recipients
por: Dimitriades, Victoria, et al.
Publicado: (2022)

Duration of infectious viral shedding in patients with mild to moderate COVID-19 treated with REGN-CoV2()
por: Nomura, Toshihito, et al.
Publicado: (2022)

Successful transfer of anti–SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19
por: Luetkens, Tim, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nm0e9tbl143j84kfffjapd7unr